Com-Guard.com, Inc.

Com-Guard.com, Inc.

CGUD
Com-Guard.com, Inc.US flagOther OTC
0.00
USD
- -
- -
508,519.00Market Cap
Com-Guard.com, Inc.
CGUD
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2000
2001
2002
2003
2004
2005
TTM
FRC
- -
- -
- -
- -
- -
- -
0.15
Revenue per Share
-0.13
-0.15
-0.2
-0.14
-0.09
- -
-0.03
Basic EPS, GAAP
-0.1
-0.05
-0.03
-0.09
-0.04
- -
-0.07
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-0.19
-0.32
-0.52
-0.52
-0.41
- -
-0.26
Book Value per Share
-0.02
-0.11
-0.29
-0.05
- -
- -
-0.01
Tangible Book Value per Share
9
10
10
14
23
- -
42
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
6
6
Sales/Revenue/Turnover
-30,604.23
- -
-14,529.83
-2,757.56
-11,657.14
-21.19
-21.19
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
-1
-1
-2
-2
-2
-1
-1
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-30,604.23
- -
-20,968.84
-2,877.74
-14,378.57
-22.4
-22.4
Profit Margin (%)
- -
-1
-3
-1
- -
-1
-1
Working Capital
- -
- -
- -
- -
- -
- -
- -
LT Debt
- -
-1
-3
-1
- -
-1
-1
Total Equity
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Dec'05
Mar'05
Jun'05
ST Debt
- -
- -
3
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
18
18
18
Market Capitalization
2
4
2

Working Capital

FRC

in mil. unless spec.
Dec'05
Mar'05
Jun'05
Total Current Assets
1
1
3
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
1
1
1
Inventories
- -
- -
- -
Total Current Liabilities
1
1
4
Payables & Accruals
1
1
1
ST Debt
- -
- -
3
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-33.32%
-758.24%
Free Cash Flow
- -
80.97%
173.8%
Net Income, GAAP
- -
5.61%
-31.1%
Sales/Revenue/Turnover
- -
- -
44,121.43%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2003
- -
- -
- -
- -
- -
2004
- -
- -
- -
- -
- -
2005
2
2
2
- -
6

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2003
-0.03
-0.04
-0.04
- -
-0.14
2004
-0.02
-0.02
-0.03
- -
-0.09
2005
- -
- -
-0.01
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2003
- -
- -
- -
- -
- -
2004
- -
- -
- -
- -
- -
2005
- -
- -
- -
- -
- -
Business
Com-Guard.com, Inc. (CGUD) develops and markets software and hardware products that provide security protection for computer hardware, software, and data in microcomputers and mobile devices. The company offers ComputerSafe, a core product that detects, protects, reports unauthorized access, and safeguards against tampering; iTrakHealth for tracking health via wearables such as Apple Watch and other platforms; secure printing solutions; tracking applications using GPS, public databases, and transactions; and blockchain implementation and development services, including planned integration on Raspberry Pi platforms for low-cost, high-performance applications targeting industries like solar. It operates primarily in the systems software and cybersecurity segments, serving personal, corporate, and industry-specific customers with a focus on enhanced system security, data protection, and asset tracking. Founded in 1998 by Edward W. Savarese and headquartered in Encinitas, California, the company maintains a development-stage profile with ongoing efforts to expand into mobile platforms like iPhone, iPad, Android, and netbooks. In recent strategic shifts, Com-Guard standardized on Raspberry Pi development platforms utilizing Linux-based software and ARM architecture hardware to deliver cost-effective solutions, with initial blockchain software targeting the solar industry. No major funding rounds, acquisitions, or partnerships have been publicly announced in the last 1-2 years, reflecting a focus on internal product evolution amid its OTC-traded status.